TerrAscend (TSNDF) Share-based Compensation (2021 - 2026)

TerrAscend's (TSNDF) quarterly Share-based Compensation came in at $885000.0 in Q1 2026, down 41.55% year-on-year from $1.5 million in Q1 2025, and down 76.27% on a QoQ basis from $3.7 million in Q4 2025.

TerrAscend (TSNDF) Share-based Compensation (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Share-based Compensation data on file, last reported at $885000.0 in Q1 2026.

  • On a quarterly basis, Share-based Compensation fell 41.55% year-over-year to $885000.0 in Q1 2026; TTM through Mar 2026 was $8.1 million, a 12.34% increase from a year earlier, with the FY2025 full-year figure at $5.0 million, down 48.41% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $885000.0, down from $3.7 million in the prior quarter.
  • Over the last five years, Share-based Compensation for TSNDF reached as high as $39.7 million in Q3 2022 and fell as low as $885000.0 in Q1 2026.
  • Historically, Share-based Compensation has averaged $8.4 million across 5 years, with a median of $3.4 million in 2022.
  • Across the five-year window, Share-based Compensation jumped 977.66% in 2022 and sank 79.35% in 2023, its largest moves.
  • Year by year, Share-based Compensation stood at $1.6 million in 2022, then jumped by 36.63% to $2.2 million in 2023, then decreased by 11.26% to $2.0 million in 2024, then surged by 87.76% to $3.7 million in 2025, then tumbled by 76.27% to $885000.0 in 2026.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $885000.0 in Q1 2026, $3.7 million in Q4 2025, and $3.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 43.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 25.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 125.69 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 58.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 56.50 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 55.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.00 Mn
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn 885,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 885,000.00
Mar 31, 2026 885,000.00
Dec 31, 2025 3.73 Mn
Dec 31, 2025 3.73 Mn
Sep 30, 2025 3.04 Mn
Sep 30, 2025 3.04 Mn
Jun 30, 2025 3.83 Mn
Jun 30, 2025 3.83 Mn
Mar 31, 2025 1.51 Mn
Mar 31, 2025 1.51 Mn
Dec 31, 2024 1.99 Mn
Dec 31, 2024 1.99 Mn
Sep 30, 2024 6.68 Mn
Sep 30, 2024 6.68 Mn
Jun 30, 2024 7.66 Mn
Jun 30, 2024 7.66 Mn
Mar 31, 2024 1.49 Mn
Mar 31, 2024 1.49 Mn
Dec 31, 2023 2.24 Mn
Dec 31, 2023 2.24 Mn